Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma

No Thumbnail Available
File version
Version of Record (VoR)
Author(s)
Uddin, Md Sahab
Kabir, Md Tanvir
Al Mamun, Abdullah
Sarwar, Md Shahid
Nasrin, Fatema
Bin Emran, Talha
Alanazi, Ibtesam S
Rauf, Abdur
Albadrani, Ghadeer M
Sayed, Amany A
Mousa, Shaker A
Abdel-Daim, Mohamed M
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2021
Size
File type(s)
Location
License
http://creativecommons.org/licenses/by/4.0/
Abstract

Nuclear factor-κB (NF-κB) is a transcription factor that regulates various genes that mediate various cellular activities, including propagation, differentiation, motility, and survival. Abnormal activation of NF-κB is a common incidence in several cancers. Glioblastoma multiforme (GBM) is the most aggressive brain cancer described by high cellular heterogeneity and almost unavoidable relapse following surgery and resistance to traditional therapy. In GBM, NF-κB is abnormally activated by various stimuli. Its function has been associated with different processes, including regulation of cancer cells with stem-like phenotypes, invasion of cancer cells, and radiotherapy resistance identification of mesenchymal cells. Even though multimodal therapeutic approaches such as surgery, radiation therapy, and chemotherapeutic drugs are used for treating GBM, however; the estimated mortality rate for GBM patients is around 1 year. Therefore, it is necessary to find out new therapeutic approaches for treating GBM. Many studies are focusing on therapeutics having less adverse effects owing to the failure of conventional chemotherapy and targeted agents. Several studies of compounds suggested the involvement of NF-κB signaling pathways in the growth and development of a tumor and GBM cell apoptosis. In this review, we highlight the involvement of NF-κB signaling in the molecular understanding of GBM and natural compounds targeting NF-κB signaling.

Journal Title
Frontiers in Pharmacology
Conference Title
Book Title
Edition
Volume
12
Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
© The Author(s) 2021. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Item Access Status
Note
Access the data
Related item(s)
Subject
Pharmacology and pharmaceutical sciences
Science & Technology
Life Sciences & Biomedicine
Pharmacology & Pharmacy
NF-kappa B
glioblastoma
Persistent link to this record
Citation
Uddin, MS; Kabir, MT; Al Mamun, A; Sarwar, MS; Nasrin, F; Bin Emran, T; Alanazi, IS; Rauf, A; Albadrani, GM; Sayed, AA; Mousa, SA; Abdel-Daim, MM, Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma, Frontiers in Pharmacology, 2021, 12, pp. 703761
Collections